--- a
+++ b/clusters/9knumclustersv2/clust_1557.txt
@@ -0,0 +1,82 @@
+Known brain metastases
+Known intracranial metastases
+Known brain metastases
+Patients with known brain metastases
+Known brain metastases
+The presence of known brain metastases
+Patient has known brain metastases,
+Patients with known brain metastases
+Known brain metastases who are clinically unstable
+Patient with a known history or evidence of brain metastases
+Patients with known brain metastases
+Known brain metastases
+Have no known metastases
+Known brain metastases or history of seizure
+Patients with known brain metastases
+Patients with known brain metastases should be excluded
+Known brain metastases
+Patients with known brain metastases
+Subjects with known metastases
+Must not have known brain metastases
+Patients with known brain metastases (treated or not) will be excluded
+Patient with a known history or evidence of brain metastases
+Subjects with known brain metastases.
+Known brain metastases
+Known brain metastases (even if treated)
+Patients with known brain metastases
+Patients with known brain metastases are excluded
+Subjects with known brain metastases
+Patients with known brain metastases
+Subjects with known brain metastases
+Patients with known brain metastases
+Known brain metastases
+Presence of or known history of brain/CNS tumor or metastases
+Have known brain metastases.
+No known brain metastases
+Known brain metastases
+Have known brain metastases.
+Patients with known brain metastases
+Known metastases to the brain
+Subject has known brain metastases
+Known brain metastases
+Patients with known metastases are not eligible
+Has known brain metastases
+Known brain metastases
+Known brain metastases
+Known brain metastases
+Patient has a known history or evidence of brain metastases
+Known brain metastases
+Patients with known brain metastases
+Known brain metastases;
+Known brain metastases, unless stable for at least  days
+Any known metastases
+Patients with known brain metastases are NOT eligible for participation
+Patients with known brain metastases
+Known presence of metastases
+Known brain metastases
+Subjects with known brain metastases and/or unresectable sarcoma
+Known brain metastases
+Known or suspected brain metastases
+Known brain metastases
+Known brain metastases.
+Subject has known brain metastases.
+Patients with known brain metastases are excluded from this study
+Patients with known brain metastases
+Patients with known brain metastases
+Subject has known brain metastases
+Patients with known brain metastases will be excluded
+Known brain metastases
+Patients with known brain metastases
+Patient must not have known active brain metastases; patients with previously treated brain metastases are eligible; patients with known brain active metastases must be excluded from this clinical trial
+Patients with known brain metastases
+Known or suspected metastases in the brain
+Known history or evidence of brain metastases
+Known brain metastases (scan required at screening)
+Known brain metastases
+Patients with known brain metastases;
+Known brain metastases
+Known history of brain metastases
+Subject has known history of brain metastases.
+Known brain metastases
+Known brain metastases
+Patients with known brain metastases